Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS)
Macfarlane, G. J., Rotariu, O., Jones, G. T., Pathan, E. M. I., Dean, L. E.
Annals of the Rheumatic Diseases, vol. 79, no. 2, pp. 202-208
Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen Prospective Osteoporosis Screening Study (APOSS)
Neal, S. R., Wood, A. D., Ablett, A. D., Gregory, J. S., Guillot, J., Macdonald, H. M., Reid, D. M., Myint, P. K.
Therapeutic Advances in Drug Safety, vol. 11, pp. 1-9
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration
Michelsen, B., Lindström, U., Codreanu, C., Ciurea, A., Zavada, J., Loft, A. G., Pombo-Suarez, M., Onen, F., Kvien, T. K., Rotar, Z., Santos, M. J., Iannone, F., Hokkanen, A., Gudbjornsson, B., Askling, J., Ionescu, R., Nissen, M. J., Pavelka, K., Sanchez-Piedra, C., Akar, S., Sexton, J., Tomsic, M., Santos, H., Sebastiani, M., Österlund, J., Geirsson, A. J., Macfarlane, G., van der Horst-Bruinsma, I., Georgiadis, S., Brahe, C. H., Ørnbjerg, L. M., Hetland, M. L., Østergaard, M.